Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-07-06 4:35 pm Purchase | 2023-07-03 | 13D | RegeneRx Biopharmaceuticals, Inc. RGRX | Essetifin SPA | 6,040 36.100% | 513 (+9.27%) | Filing History |
| 2021-07-02 4:15 pm Purchase | 2021-06-30 | 13D | RegeneRx Biopharmaceuticals, Inc. RGRX | Essetifin SPA | 5,527 34.100% | 375 (+7.28%) | Filing History |
| 2020-10-16 4:16 pm Purchase | 2020-10-15 | 13D | RegeneRx Biopharmaceuticals, Inc. RGRX | Essetifin SPA | 5,152 34.400% | 195 (+3.93%) | Filing History |
| 2020-05-04 5:22 pm Purchase | 2020-04-30 | 13D | Fennec Pharmaceuticals Inc. FENC | Essetifin SPA | 3,993,694 16.200% | 768,000 (+23.81%) | Filing History |